Effects of Renal Denervation on Cardiac Remodeling, Cardiac Function, and Cardiovascular Neurohormones in Heart Failure with Reduced Ejection Fraction Patients: A Meta-Analysis and Systematic Review.
{"title":"Effects of Renal Denervation on Cardiac Remodeling, Cardiac Function, and Cardiovascular Neurohormones in Heart Failure with Reduced Ejection Fraction Patients: A Meta-Analysis and Systematic Review.","authors":"Fei Si, Qian Liu, Xin Ma, Jing Yu","doi":"10.1159/000545078","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effects of Renal Denervation (RDN) on cardiac remodeling, cardiac function, and cardiovascular (CV) neurohormones in heart failure patients with reduced ejection fraction (HFrEF).</p><p><strong>Methods: </strong>We searched PubMed, Embase, Web of Science, and China National Knowledge Infrastructure (CNKI), identifying 6 randomized controlled trials (RCTs) and 9 single-arm studies, totaling 352 participants. Meta-analyses for RCTs and single-arm studies were conducted using STATA 17 software and the metafor package in R, respectively.</p><p><strong>Results: </strong>In RCTs, RDN significantly reduced left ventricular end-diastolic diameter (LVEDD) (WMD=-3.55 mm, 95% CI [-5.51, -1.59], P<0.01), left ventricular end-systolic diameter (LVESD) (WMD=-4.13 mm, 95% CI [-6.08, -2.18], P<0.01), and significantly increased left ventricular ejection fraction (LVEF) (WMD=6.30%, 95% CI [4.64, 7.96], P<0.01) and 6-minute walk test (6MWT) distance (WMD=51.25 m, 95% CI [8.30, 94.20], P<0.05). brain natriuretic peptide (BNP) or N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels were significantly reduced (SMD=-1.24, 95% CI [-1.57, -0.90], P<0.01). In single-arm studies, RDN significantly reduced LVEDD (MC=-2.41 mm, 95% CI [-3.74, -1.09], P<0.01), LVESD (MC=-1.72 mm, 95% CI [-2.77, -0.67], P<0.01), LAD (MC=-1.62 mm, 95% CI [-3.16, -0.08], P<0.01), and interventricular septal thickness (IVST) (MC=-0.76mm, 95% CI [-1.05, -0.47], P<0.01). RDN significantly increased LVEF（MC=29.52%, 95% CI [ 12.74, 46.31], P<0.01）and 6MWT distance (MC=100.49 m, 95% CI [49.12, 151.86], P<0.05). RDN significantly reduced BNP or NT-proBNP levels (SMC=-0.57, 95% CI [-0.83, -0.31], P<0.01). Our study also found that RDN had varying degrees of reduction on Renin, Angiotensin II, Aldosterone, and Norepinephrine (NE) in HFrEF patients. Additionally, we found that RDN had no significant effect on SBP/DBP in HFrEF patients, but reduced heart rate (WMD=-7.22 bpm, 95% CI [-9.84, -4.60], P<0.01).</p><p><strong>Conclusion: </strong>Our meta-analysis demonstrates that RDN can improve cardiac remodeling, enhance cardiac function, reduce CV neurohormones and has no significant effect on blood pressure in patients with HFrEF.</p>","PeriodicalId":9584,"journal":{"name":"Cardiorenal Medicine","volume":" ","pages":"1-23"},"PeriodicalIF":2.4000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiorenal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000545078","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To evaluate the effects of Renal Denervation (RDN) on cardiac remodeling, cardiac function, and cardiovascular (CV) neurohormones in heart failure patients with reduced ejection fraction (HFrEF).
Methods: We searched PubMed, Embase, Web of Science, and China National Knowledge Infrastructure (CNKI), identifying 6 randomized controlled trials (RCTs) and 9 single-arm studies, totaling 352 participants. Meta-analyses for RCTs and single-arm studies were conducted using STATA 17 software and the metafor package in R, respectively.
Results: In RCTs, RDN significantly reduced left ventricular end-diastolic diameter (LVEDD) (WMD=-3.55 mm, 95% CI [-5.51, -1.59], P<0.01), left ventricular end-systolic diameter (LVESD) (WMD=-4.13 mm, 95% CI [-6.08, -2.18], P<0.01), and significantly increased left ventricular ejection fraction (LVEF) (WMD=6.30%, 95% CI [4.64, 7.96], P<0.01) and 6-minute walk test (6MWT) distance (WMD=51.25 m, 95% CI [8.30, 94.20], P<0.05). brain natriuretic peptide (BNP) or N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels were significantly reduced (SMD=-1.24, 95% CI [-1.57, -0.90], P<0.01). In single-arm studies, RDN significantly reduced LVEDD (MC=-2.41 mm, 95% CI [-3.74, -1.09], P<0.01), LVESD (MC=-1.72 mm, 95% CI [-2.77, -0.67], P<0.01), LAD (MC=-1.62 mm, 95% CI [-3.16, -0.08], P<0.01), and interventricular septal thickness (IVST) (MC=-0.76mm, 95% CI [-1.05, -0.47], P<0.01). RDN significantly increased LVEF（MC=29.52%, 95% CI [ 12.74, 46.31], P<0.01）and 6MWT distance (MC=100.49 m, 95% CI [49.12, 151.86], P<0.05). RDN significantly reduced BNP or NT-proBNP levels (SMC=-0.57, 95% CI [-0.83, -0.31], P<0.01). Our study also found that RDN had varying degrees of reduction on Renin, Angiotensin II, Aldosterone, and Norepinephrine (NE) in HFrEF patients. Additionally, we found that RDN had no significant effect on SBP/DBP in HFrEF patients, but reduced heart rate (WMD=-7.22 bpm, 95% CI [-9.84, -4.60], P<0.01).
Conclusion: Our meta-analysis demonstrates that RDN can improve cardiac remodeling, enhance cardiac function, reduce CV neurohormones and has no significant effect on blood pressure in patients with HFrEF.
期刊介绍：
The journal ''Cardiorenal Medicine'' explores the mechanisms by which obesity and other metabolic abnormalities promote the pathogenesis and progression of heart and kidney disease (cardiorenal metabolic syndrome). It provides an interdisciplinary platform for the advancement of research and clinical practice, focussing on translational issues.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
